WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
5,85 ฿
0,00%
(0,00) 1D
9. okt., 16.40.00 GMT+7 · THB
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for WUXI06...
Åbn
5,55 ฿
Høj
5,85 ฿
Lav
5,45 ฿
Markedsværdi
221,69 mia.
Gns. vol.
107,60 t
Volumen
151,86 t
Højeste i 52 uger
6,25 ฿
Laveste i 52 uger
3,02 ฿
Aktier i omløb
4,12 mia.
Antal ansatte
15 t
Åbn
5,55 ฿
Høj
5,85 ฿
Lav
5,45 ฿
Markedsværdi
221,69 mia.
Gns. vol.
107,60 t
Volumen
151,86 t
Højeste i 52 uger
6,25 ฿
Laveste i 52 uger
3,02 ฿
Aktier i omløb
4,12 mia.
Antal ansatte
15 t
Nyhedshistorier
Fra webkilder og nyhedspartnere
Simply Wall Street
·
for 27 minutter siden
What AVITA Medical Holders Bought Into Before A 281% Run
The Globe and Mail
·
for 56 minutter siden
How to Beat a Choppy Market With 4 Steady Stocks
Yahoo Finance
·
for 1 time siden
The S&P 500 Just Hit a Record High -- Here's How Much Higher It Can Climb, According to the Wall Street Consensus
24/7 Wall St.
·
for 4 timer siden
KLA Turned $1,000 Into $31,595 in a Decade, Crushing the S&P 500 by 8.7x
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Om Wuxi Biologics (Cayman) Inc. KKPS DR
Administrerende direktørZhisheng Chen
Ansatte14,7 t
Grundlagt2010
Hovedsæde-
Sektor-
Websitewuxibiologics.com